Reply to the Editor regarding "Neoadjuvant chemotherapy improves overall survival in stage III but not in stage II colon cancer: A propensity score-matched analysis of the National Cancer Database".

IF 3.2 2区医学 Q1 SURGERY

Surgery Pub Date : 2025-06-24 DOI:10.1016/j.surg.2025.109516

Nir Horesh, Sameh Hany Emile, Steven Wexner

引用次数: 0

查看原文本刊更多论文

回复编辑关于“新辅助化疗提高了III期结肠癌的总生存率，但没有提高II期结肠癌的总生存率：国家癌症数据库的倾向评分匹配分析”。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Surgery 医学-外科

CiteScore

5.40

自引率

5.30%

发文量

687

审稿时长

64 days

期刊介绍： For 66 years, Surgery has published practical, authoritative information about procedures, clinical advances, and major trends shaping general surgery. Each issue features original scientific contributions and clinical reports. Peer-reviewed articles cover topics in oncology, trauma, gastrointestinal, vascular, and transplantation surgery. The journal also publishes papers from the meetings of its sponsoring societies, the Society of University Surgeons, the Central Surgical Association, and the American Association of Endocrine Surgeons.